Interstitial Lung Disease Research Unit Biobank
Recruiting
Observational Study
Interstitial Lung Disease
Sarcoidosis
Idiopathic Pulmonary Fibrosis
Pulmonary Fibrosis
Hypersensitivity Pneumonitis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- University of Kansas Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
2. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.
3. The participan…
Contacts